LncRNA growth arrest-specific transcript 5 targets miR-21 gene and regulates bladder cancer cell proliferation and...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Bladder cancer remains a significant health concern with complex regulatory mechanisms.
• Growth arrest-specific transcript 5 (GAS5) is a long non-coding RNA implicated in various cellular processes.
• Understanding the role of GAS5 in bladder cancer is crucial for developing targeted therapies.

Purpose of the Study:

• To elucidate the regulatory mechanism of GAS5 in bladder cancer cells.
• To investigate the interaction between GAS5, miR-21, and PTEN in bladder cancer.
• To correlate GAS5 and miR-21 expression levels with patient survival rates.

Main Methods:

• Analysis of bladder cancer patient samples.
• Dual-luciferase reporter assays to identify downstream targets of GAS5 and miR-21.
• Quantitative assessment of GAS5 and miR-21 expression levels.
• In vitro assays to evaluate effects on cell proliferation and apoptosis.

Main Results:

• GAS5 expression was inversely correlated with miR-21 expression in bladder cancer tissues.
• GAS5 demonstrated inhibitory effects on bladder cancer cell proliferation and promoted apoptosis.
• miR-21 was identified as a direct target of GAS5, and PTEN as a direct target of miR-21.
• High GAS5 and low miR-21 levels correlated with improved patient survival.

Conclusions:

• GAS5 exerts antiproliferative and proapoptotic effects on bladder cancer cells via the miR-21/PTEN pathway.
• The GAS5/miR-21/PTEN axis represents a potential therapeutic target for bladder cancer.
• GAS5 and miR-21 levels may serve as prognostic biomarkers for bladder cancer patients.